Finlay A. McAlister, MD, MSc

General Internist, University of Alberta Hospital
University of Alberta, Canada

Poster(s):

• (P159) EVALUATING THE BURDEN OF DIABETES ON HEART FAILURE RELATED MEDICAL OPTIMIZATION AND HEALTH STATUS IN A SPECIALIZED CLINIC-BASED COHORT
  Saturday, October 26, 2024

  1:30 PM – 2:00 PM PT

• (P163) HYPERKALEMIA-RELATED HEART FAILURE THERAPY DISCONTINUATION AND ITS ASSOCIATION WITH ADVERSE OUTCOMES IN PATIENTS WITH HEART FAILURE: A POPULATION-BASED STUDY
  Saturday, October 26, 2024

  9:45 AM – 10:45 AM PT

• (P168) LOW BODY TEMPERATURE IN HEART FAILURE PATIENTS; PREVALENCE AND OUTCOMES
  Friday, October 25, 2024

  1:30 PM – 2:00 PM PT

• (P182) THE DIAGNOSTIC AND PROGNOSTIC ROLE OF CARDIAC BIOMARKERS IN PREDICTING MAJOR ADVERSE CARDIAC EVENTS IN PATIENTS WITH SUSPECTED GENETIC CARDIOMYOPATHIES
  Saturday, October 26, 2024

  1:30 PM – 2:00 PM PT

• (P185) THE RELATIONSHIP OF DIURETICS AND DIETARY SODIUM IN PATIENTS WITH HEART FAILURE: AN ANALYSIS OF THE SODIUM-HF TRIAL
  Saturday, October 26, 2024

  1:30 PM – 2:00 PM PT

• (P193) FACTORS ASSOCIATED WITH DEVELOPMENT OF SEVERE MR IN PATIENTS WITH HF
  Friday, October 25, 2024

  12:00 PM – 12:30 PM PT